StradBio, Inc.
PrivateLast Round
Accelerator
Jul 7, 2025
Company Overview
StradBio, Inc. is a biotechnology company that develops engineered cytokine-based immunotherapies for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StradBio, Inc. Comparables
Compare StradBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Soteria Biotherapeutics | 82% | |
| Bright Peak Therapeutics | 77% | |
| Asher Biotherapeutics | 75% |
StradBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 7, 2025 |
StradBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Toronto Asset Management Corporation | Accelerator |
| Creative Destruction Lab | Accelerator |
StradBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about StradBio, Inc.'s valuation, stock price, and market status.
Is StradBio, Inc. a public or private company?
StradBio, Inc. is a private company.
What is the current stock price of StradBio, Inc.?
StradBio, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is StradBio, Inc. worth (valuation)?
Valuation information for StradBio, Inc. is not publicly available.
Can I buy StradBio, Inc. stock?
StradBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was StradBio, Inc.'s last funding round?
StradBio, Inc.'s most recent funding round was Accelerator on July 7, 2025.
Who are the main investors in StradBio, Inc.?
Key investors in StradBio, Inc. include University of Toronto, Creative Destruction Lab.
Will StradBio, Inc. IPO soon?
No public IPO plans have been announced for StradBio, Inc..
How can I track StradBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StradBio, Inc.'s secondary market activity and sign up for updates.